Moovit makes it simple and fast to find the best route to Lilly Technology Center – North Campus Building 361. Simply provide your location or nearby landmarks and see how far away your destination lies.
Lilly will assist Ivy Tech students over the next five years through a new scholarship program with access to an intelligent manufacturing lab, specifically targeting first-generation students and those overcoming socioeconomic disadvantages to obtain credentials in pharmaceutical manufacturing or quality.
Lilly unites caring with discovery to make medicines that make life better for people worldwide.
Lilly brings caring and discovery together to produce medicines that help people live better lives around the globe. Their history of supporting education and communities spans over six decades, with facilities such as Wake Technical Community College’s Lilly Science and Technology Center providing intelligent learning environments for their new Biotechnology Associate of Applied Science degree and non-degree BioWork certificate program.
This innovative facility boasts intelligent classrooms, state-of-the-art science labs, and collaborative spaces – including the Lighthouse Aseptic Suite- allowing students to gain experience working in controlled environment laboratories like gowning, sterile gloving, pipetting, and material transfer. Furthermore, there is also an Amgen Co-Laboratory, FujiFilm Diosynth Biotechnologies Early College Suite, and Sam Taylor BioWork Lab for industry collaborations.
Lilly is committed to using its expertise to address global health challenges like tuberculosis, non-communicable diseases, and hunger through its Connecting Hearts Abroad program, to improve access to medical care while increasing people in developing countries’ abilities to take control of their healthcare.
Lilly strives to form partnerships that support healthcare systems, increase access to affordable medications and increase healthcare delivery and efficiency – initiatives that may lead to more effective treatments for severe conditions and improved care for vulnerable populations.
Lilly seeks to achieve its mission by recruiting and retaining top employees. It provides competitive compensation, benefits, and career advancement opportunities and supports community organizations that enhance health and well-being within local communities through its employee volunteer program.
This press release contains forward-looking statements defined by the Private Securities Litigation Reform Act of 1995 regarding Lilly and Purdue’s recent collaborations and commitments, reflecting current beliefs and expectations; however, there can be no assurance that these will yield desired results. Several risks and uncertainties could cause actual results to vary materially from those contained within forward-looking statements, including risks related to consummating proposed transactions, drug development, economic conditions, and other factors described by Lilly in its filings with the Securities and Exchange Commission.
Lilly invests in U.S.-based manufacturing.
Lilly recently announced its plans to invest an additional $1.6 billion into two new sites in Boone County, Indiana, creating up to 700 highly skilled jobs with this investment. These investments will increase Lilly’s capacity to produce active pharmaceutical ingredients and support future therapeutic modalities.
Lilly also announced a $15 million commitment to Ivy Tech Foundation, specifically to fund scholarships for students interested in pharmaceutical manufacturing careers. This announcement expands a program launched last fall, which provided up to 100 students with full-tuition scholarships and guaranteed internships at Lilly for ten years.
Lilly recently made several investment announcements. Last year, they reported a $500 million investment into Raheen Biologics Plant in Ireland; in 2020, they reported another $470 million investment into North Carolina’s Research Triangle Park. All these investments will help Lilly meet rising global demands for medicines that improve lives around the globe.
Lilly USA is committed to building a reliable domestic supply chain for its essential medications, with a particular focus on cost reduction through expanding production facilities and developing relationships with suppliers. By doing this, they aim to better compete against generic manufacturers while meeting more Americans’ needs for critically necessary drugs.
As part of its investment in new manufacturing plants in the US, Toyota has also invested substantially in Indiana facilities since 2012. Since 2012, over $5 billion has been committed by Toyota in Indiana facilities. Lilly’s most recent investment will increase Indiana employment levels to more than 30,000, an increase that exceeds twofold from 2012. Lilly’s investment will bring with it 500 temporary construction jobs in Indiana and support hundreds of indirect positions throughout Indiana. Furthermore, Lilly is expanding their presence in Ireland, where they currently have two manufacturing campuses: Kinsale in Kinsale County Cork and Little Island in County Cork.
Lilly Scholars program
Lilly Endowment Inc. created the Lilly Scholars program as a scholarship initiative designed to raise educational attainment levels in Indiana while increasing awareness of community foundations’ abilities to enhance the quality of life in their local areas. Through the Lilly Scholars initiative, Indiana students can earn certification in pharmaceutical manufacturing or quality and experience preferred access and coordinated interactions with company leaders – these opportunities are administered locally by Hendricks County Community Foundation and statewide through Independent Colleges of Indiana.
Lilly Scholars Program requires high school seniors to submit an application, which will be evaluated by a committee of two former Lilly Scholars. Each applicant will be judged based on character, academic performance, leadership experience, community involvement, and personal goals. Once selected for an interview round, top applicants are subjected to further assessments that assess communication skills, commitment, and enthusiasm toward their field of study and future goals.
Lilly Scholars will receive full tuition at Purdue, guaranteed internship or co-op opportunities with company leaders, and a stipend to cover books and equipment. This program was established to attract top academic performers capable of working with the precision and dedication required in pharmaceutical manufacturing; therefore, they must maintain at least a 3.5 unweighted GPA at graduation, as Lilly Scholars must return any portion of the allocation left over from books and equipment that remains at completion of their baccalaureate course of study.
Hendricks County Community Foundation of Indiana oversees the Lilly Endowment Community Scholarship Program to aid low-income students in attaining a college education and thriving in pharmaceutical or quality industries, helping meet a need for qualified workers throughout Hendricks County and Indiana.
Lilly Scholars @ Ivy Tech was established to assist students seeking pharmaceutical manufacturing and quality qualifications at Ivy Tech Hendricks County, Indiana. Students will not only receive scholarships but will also have access to experiential learning and professional development opportunities through this program – which is open to any Indiana resident meeting the eligibility requirements.
Lilly’s LEAP Innovation Park expansion
Lilly announced plans to invest $1.6 billion and create 200 jobs at two new manufacturing sites within LEAP Innovation Park in Boone County. This expansion marks their most significant manufacturing investment in any one place. This investment should enable the company to meet the demand for diabetes medications and those treating other illnesses, such as autoimmune disorders. Furthermore, it will allow it to expand both active ingredient pharmaceutical capacity and device assembly capabilities. These new facilities will include a syringe fill line, an operational pharmaceutical ingredients plant, and device assembly facilities. Furthermore, the company has pledged $15 million over five years to Ivy Tech Foundation to fund scholarships for individuals interested in careers in pharmaceutical production.
Lilly plans to use its planned manufacturing sites to increase Lilly’s capacity for active ingredients used to manufacture medicine, new therapeutic modalities such as genetic medicines, and an expanded portfolio of potentially life-changing treatments for patients worldwide. As well as creating 500 full-time jobs through this project, indirect job opportunities could reach 2,000 indirect ones with suppliers supporting them.
According to a company presentation, this $2.1 billion project would comprise twelve buildings near Lebanon that currently house a water treatment plant. These range from a 3,200-square-foot visitor center to three-story, 330,000-square-foot manufacturing facilities that would need local zoning and annexation approvals for construction. The Indiana Economic Development Corp will assist the company with this endeavor as part of their plan to construct these sites by 2023.
Lilly has taken steps to expand its manufacturing footprint in the US while increasing investment in research and development programs as part of a 10-year program with Purdue University to offer students access to innovative manufacturing labs and guarantee internships or co-ops for graduates from that program. Furthermore, Lilly will give scholarships to those from low-income families or who are the first in their family to attend college.
